摘要
Objectives: Hypertension is thought to be a contributor to mortality in coronavirus disease 2019 patients; however, limited clinical data on the outcomes of COVID-19 in patients with hypertension are available. @@@ Methods: This study was designed to confirm whether hypertension affects the outcomes of COVID-19. @@@ Results: A total of 983 patients with COVID-19 (female, 48%; male, 52%) were enrolled. Significantly higher odds of 60-day mortality (p = .017) were observed in the hypertensive group. In the hypertensive group, even after adjustment in multivariate analysis, the subgroup of patients 70 years old and older had higher 28-day mortality and total 60-day mortality rates than the other age subgroups (bothp < .05). A total of 297 (89%) COVID-19 patients with hypertension survived, and 35 (11%) died. In addition, compared with hypertensive patients who survived COVID-19, non-survivors had more pre-existing conditions, including cardiovascular diseases and stroke, higher blood pressure on admission, more severe inflammation, and more liver and kidney damage. @@@ Conclusion: Hypertension does not affect the outcome of COVID-19, which is different than the conclusions drawn in other studies. However, the 28-day mortality and total 60-day mortality rates of hypertensive patients (age >= 70) with COVID-19 were significantly elevated, and compared with the group of survivors, non-surviving COVID-19 patients with hypertension were older, had more basic diseases and had a more severe clinical condition.
学科与关键词
- Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysisQian, Zhe; Li, Zhuohong; Peng, Jie; Gao, Qiqing; Cai, Shaohang*; Xu, Xuwen*Clinical and Experimental Hypertension, 2022, 44(5): 451-458.被引 9
- Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective studyChen, Jiankun; Liu, Yuntao; Qin, Jinying; Ruan, Chunyan; Zeng, Xianghui; Xu, Aiting; Yang, Rongyuan*; Li, Jiqiang*; Cai, Huayang*; Zhang, ZhongdePostgraduate Medical Journal, 2022, 98(1161): 515-522.被引 16
- Hypertension and COVID-19.Schiffrin, Ernesto L; Flack, John M; Ito, Sadayoshi; Muntner, Paul; Webb, R Clinton2020-04-29.
